PHARMAREVIEW LIMITED
Get an alert when PHARMAREVIEW LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Cash
—
Latest balance sheet
Net assets
£48m
+608.4% highest in 5 filed years
Employees
28
-61.6% lowest in 5 filed years
Profit before tax
£48m
+819.1% highest in 3 filed years
Watchouts
Facts from the Companies House register and the latest accounts — not a rating
-
Accounts not prepared on a going-concern basis
The company's trade and assets of Pharmareview Limited have been hived up into IQVIA Limited on 1 July 2025. Subsequently, the Company is being dissolved, therefore it is not considered appropriate to adopt the going concern basis of accounting in preparing the financial statements. Accordingly the financial statements have been prepared on a basis other than going concern.
-
1 PSC ceased in last 24 months
Significant control changed hands — see the Ownership section.
-
Going-concern uncertainty disclosed
Net assets
5-year trend · vs Industrials median
Accounts
5-year trend · Δ = latest vs prior filed period · latest reflected 2025-12-31
| Metric | Trend | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | Δ vs prior |
|---|---|---|---|---|---|---|---|
| Turnover | — | — | £10,548,332 | £10,516,724 | £6,000,053 | -42.9% | |
| Operating profit | — | — | £2,130,936 | £5,199,680 | £47,805,137 | +819.4% | |
| Profit before tax | — | — | £2,140,106 | £5,201,539 | £47,805,137 | +819.1% | |
| Net profit | £1,855,654 | £2,921,176 | £2,009,335 | £5,215,277 | £47,805,137 | +816.6% | |
| Cash | £1,213,218 | £1,623,153 | £1,981,586 | £5,290,701 | — | — | |
| Total assets less current liabilities | £2,574,978 | £3,145,726 | £5,110,223 | £6,789,330 | £48,094,467 | +608.4% | |
| Net assets | £2,561,254 | £3,100,888 | £5,110,223 | £6,789,330 | £48,094,467 | +608.4% | |
| Equity | £2,561,254 | £3,100,888 | £5,110,223 | £6,789,330 | £48,094,467 | +608.4% | |
| Average employees | 33 | 63 | 94 | 73 | 28 | -61.6% | |
| Wages | — | — | £4,973,810 | £4,157,864 | £1,451,790 | -65.1% | |
| Directors' remuneration | — | — | £415,482 | £0 | — | — | |
| Directors' pension contributions | £NaN | £NaN | £1,717 | £0 | £NaN | — | |
| Highest paid director | £NaN | £NaN | £238,366 | £0 | £NaN | — |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. The Δ column is the change from the prior filed period as a percentage of |prior|; lines a company doesn't report show —. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|---|---|---|
| Operating margin | — | — | 20.2% | 49.4% | — | |
| Net margin | — | — | 19.0% | 49.6% | — | |
| Return on capital employed | — | — | 41.7% | 76.6% | 99.4% | |
| Gearing (liabilities / total assets) | 29.2% | 28.1% | 16.6% | 23.0% | 0.0% | |
| Current ratio | — | — | 5.95x | 4.34x | — |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Margin ratios are hidden where reported turnover is too small relative to profit to yield a meaningful figure — typical of holding companies whose income is mostly subsidiary dividends rather than trading revenue. Sector-distribution context coming next.
Audit & accounting basis
- Accounting basis
- FRS 102
- Reporting scope
- Standalone (parent only)
- Abridged
- Yes — abridged accounts (limited disclosure)
- Auditor
- Menzies LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Not a going concern (break-up basis)
“The company's trade and assets of Pharmareview Limited have been hived up into IQVIA Limited on 1 July 2025. Subsequently, the Company is being dissolved, therefore it is not considered appropriate to adopt the going concern basis of accounting in preparing the financial statements. Accordingly the financial statements have been prepared on a basis other than going concern.”
Significant events
- “The company's trade and assets were hived up into parent company IQVIA Limited on 1 July 2025.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
3 active · 7 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| JTC (UK) LIMITED | Corporate Secretary | 2023-08-31 | — | — |
| KOTCHIE, Robert | Director | 2023-08-31 | Jan 1979 | British |
| PARK, Graham Russell | Director | 2023-08-31 | Sep 1974 | British |
Show 7 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| NAKIELNY, Joanna Margaret, Dr | Secretary | 2011-10-04 | 2014-11-25 |
| CARTER, Ralph Trevor Jacobus, Dr | Director | 2011-10-04 | 2023-08-31 |
| DONOGHUE, Stella Mary | Director | 2021-07-01 | 2023-08-31 |
| FINLAY, Ross Frazer | Director | 2023-02-13 | 2023-08-31 |
| GARLICK, Robert James | Director | 2022-07-19 | 2022-12-14 |
| PUGH, Tessa Louise | Director | 2013-01-01 | 2023-08-31 |
| SHARMA, Sangeeta | Director | 2021-07-01 | 2022-06-23 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Iqvia Ltd. | Corporate entity | Shares 75–100%, Voting 75–100% | 2024-12-02 | Active |
| Phr Bidco Limited | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2021-07-01 | Ceased 2024-12-02 |
| Dr Ralph Trevor Jacobus Carter | Individual | Shares 50–75% | 2016-04-06 | Ceased 2021-07-01 |
| Mrs Tessa Louise Pugh | Individual | Shares 25–50% | 2016-04-06 | Ceased 2021-07-01 |
Filing timeline
Last 20 of 77 total filings
Material constitutional events — rename, articles re-file, resolution
- 2024-04-29 RESOLUTIONS Resolution
- 2023-09-15 MA Memorandum articles
- 2023-09-15 RESOLUTIONS Resolution
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-08-20 | AA | accounts | Accounts with accounts type full | |
| 2026-07-26 | AP01 | officers | Appoint person director company with name date | |
| 2026-07-24 | TM01 | officers | Termination director company with name termination date | |
| 2026-02-13 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2025-08-13 | AA | accounts | Accounts with accounts type full | |
| 2025-02-06 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2025-01-13 | PSC07 | persons-with-significant-control | Cessation of a person with significant control | |
| 2025-01-13 | PSC02 | persons-with-significant-control | Notification of a person with significant control | |
| 2024-08-19 | AA | accounts | Accounts with accounts type small | |
| 2024-04-29 | RESOLUTIONS | resolution | Resolution | |
| 2024-02-19 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-02-05 | PSC05 | persons-with-significant-control | Change to a person with significant control | |
| 2023-09-15 | MA | incorporation | Memorandum articles | |
| 2023-09-15 | RESOLUTIONS | resolution | Resolution | |
| 2023-09-13 | TM01 | officers | Termination director company with name termination date | |
| 2023-09-13 | TM01 | officers | Termination director company with name termination date | |
| 2023-09-13 | TM01 | officers | Termination director company with name termination date | |
| 2023-09-13 | TM01 | officers | Termination director company with name termination date | |
| 2023-09-13 | AP01 | officers | Appoint person director company with name date | |
| 2023-09-12 | AD01 | address | Change registered office address company with date old address new address |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 4
- Capital events
- 0
- Officers appointed
- 0
- Officers resigned
- 0
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.